Reason for request
Inclusion
Clinical Benefit
| Moderate |
Moderate AB pending re-assessment of oral antihistamines. |
Clinical Added Value
| no clinical added value |
No improvement in actual benefit (IAB V) compared with other oral H1 antihistamines available in oral form. |
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
CmJg19pmgFpU7MK2
Listen
